| Home
> Table of Contents
> Case Reports |
| |
| Vulvar Carcinoma in a Very
Young HIV Positive Woman : An Unusual Case |
| |
| Meghana Mathure*, J J Kansaria**,
SV Parulekar *** |
| |
| A very young woman with HIV
infection presented with vulval cancer ulcer involving the mons
pubis. HIV positive women are at increased risk of vulvar carcinoma
at a young age due to immunocompromised state. The vulvar carcinomatous
ulcer healed completely with dressing and secondary suturing,
first reported case in Engish world literature. |
| |
| Introduction |
| HIV infected women may be at higher risk for
developing vulvar cancer,1 because this carcinoma is more common in immunosuppressed patients than in immunocompetent controls.2 |
| |
| Case Report |
RJ, a 26 year old housewife married since
4 years presented to our out patient gynaecological department
with complaints of vulval ulcer with foul smelling discharge
since one month.
The patient complained of small break in the upper vagina
above the urethral opening one-month back with discharge,
which progressively increased in size to around 4 x 4
cm. and expanded towards lower abdomen.
She had a foul smelling discharge and pain at the vulval
ulcer site. She had no history of multiple sexual partners,
blood transfusion. She was unsure of her husband’s
sexual history. She had no history of local vulval trauma,
local application of chemicals, and no history of growth
initially over the site. She had regular present and past
menstrual cycles. She was Gravida 1, Para 1, Living 1;
with one FTND, female child of 2 years alive and well.
No other significant past history.
On examination, general condition was fair.
Local examination of vulva revealed a vulval ulcer involving
the clitoris of 4 x 4 cm size triangular shaped with base,
extending upto and involving the mons pubis. The depth
of the ulcer was 1 to 1.5 cm only. There was irregular
shaggy discharge on the floor of the ulcer and base was
firm, indurated and extremely tender.
Pap smear, Per speculum and Per vaginum examination was
not possible in view of extreme local tenderness.
She was referred to the skin OPD in view of provisional
diagnosis of chanchroid.
The dermatologist gave a clinical diagnosis of phagodenic
chanchroid. The Gram stain smear was negative; there was
absence of Tzanck cells on smear. She was treated with
T. Ciprofloxacin 500 mg. b.d. On follow up 14 days later,
the ulcer had not healed but had further extended onto
the mons pubis and the lower abdomen. There was presence
of friable shaggy necrotic tissue in the floor of the
ulcer towards the clitoris. The upper part of the vulva
involving the mons pubis and lower abdomen had profuse
purulent discharge and edges everted. Inguinal lymph nodes
were not palpable. ELISA test for HIV infection was positive
(pre- and post-est counselling done); VDRL tests negative
for both husband and wife.
The patient was referred back to us for admission and
management of non-healing vulval ulcer (Fig. 1). Culture
swab report of the vulval discharge showed Pseudomonas
aeruginosa (Gram negative bacilli) sensitive to Ciprofloxacin
and Amikacin. Patient was started on Injection Amikacin
500 mg. i.v. o.d. and local dressing twice a day. After
the control of local infection, surgical debridement of
the wound was done and biopsy obtained from the edges
of the ulcer, send for histopathological examination.
The wound infection was controlled and then secondary
suturing of the wound was done.
 |
 |
Fig. 1 : Non-healing vulval ulcer involving the mons pubis with shaggy necrotic slough seen in the floor of the ulcer. |
Fig. 2 : Histopathological picture of Squamous cell Ca. of Vulva. The arrow points towards the pearl body which is not completely pink. |
The histopathological report could not be obtained on
scheduled time before secondary suturing due to technical
difficulties. The histopathological report revealed Invasive
vulval squamous cell carcinoma (Fig. 2).
On follow up, the ulcer had healed completely on suture
removal done on day 12. Patient was referred to Tata Memorial
Hospital for further management, where she failed to follow
up for further treatment due to social reasons and HIV
positivity.
|
| |
| Discussion |
Young age at presentation, HIV positivity, vulval ulcer
extending onto the mons pubis and lower abdominal wall
causing infective necrosis of tissue over mons pubis are
important determinants in this case.
Carcinoma of the vulva is usually an uncommon disease
commonly seen in elderly postmenopausal women in the sixties
and rarely observed in women younger than 30 years of
age.3
Association of HIV infection and predisposition of HIV
infected women (immunocompromised state) to malignancies
makes an important link predisposing these very young
women to vulval cancer.
The cause of vulval cancer is unknown but it is reasonable
to suppose that any long standing irritative agent, chemical,
infective or mechanical, especially if combined with poor
hygiene, can be an aetiological factor.4
Spread of vulvar carcinoma by continuity occurs to the
vagina, urethra, and rectum. Spread to the skin over mons
pubis has not been reported. In our case, spread to mons
pubis was seen.5
Clitoral lymphatic drainage occurs partly through lymphatic
channels over the symphysis pubis to external iliac nodes,
or along the dorsal vein of clitoris to the obturator
lymph nodes. However, implantation of malignant cells
along the course of lymphatics carrying them does not
occur in vulvar carcinoma, unlike melanoma. Thus it could
not have been the mechanism of involvement of the skin
over the mons pubis.5
Primary carcinoma of the vulva is characteristically
a disease of the seventh and eighth decades of life but
the average age of patients in whom it is preceded by
granulomatous disease is about 40 years.6
Our patient’s immunocompromised state predisposed
her to vulval cancer though she was young and not having
advanced HIV infection. We did not have CD4 levels due
to financial constraints and patient did not have any
opportunistic infections.
Women who are immunosuppressed because of HIV infection
have a high prevalence of multicentric lower genital tract
intraepithelial neoplasia and HPV infection and respond
poorly to conventional treatment.6 Giaquinto et al has
reported carcinoma of the vulva in a 12 year old girl
with vertically acquired Human Immunodeficiency Virus
Infection.7
A unique feature about our case is its early onset and
it healed completely with dressing and secondary suturing
although Ca vulva should not have healed. It is likely
to grow again. This is first reported case of Ca vulva,
which has healed completely in Medline search of world
English literature.
|
| |
| References |
| 1. |
Kuhn L, Sun X-W, Wright
TC. Human immunodeficiency virus infection and lower
genital tract malignancy. Curr Opin Obstet Gynecol
1999; 11: 35-9. |
| 2. |
Carter J, Carlson J, Fowler J, Invasive
vulvar tumors in young women – a disease of
the immunosuppressed? Gynecol Oncol 1993; 51: 307-10. |
| 3. |
Chhoc YC. Invasive squamous carcinoma
of the vulva in young patients. Gynecol Oncol 1982;
13:158-64. |
| 4. |
effcoate’s Principles of Gynaecology.
Fifth edition. Butterworth and Co. Heinemann International
edition. 1990. Chapter 23. Tumors of vulva. pp. 371-88. |
| 5. |
Parsnis HB, Parulekar SV. Invasive
Carcinoma of the Vulva. In Clinical Manual of Gynecologic
Oncology. First edition, Bhalani Publishing house,
Mumbai, 1995;pp. 386-407. |
| 6. |
Novak ER, Woodruff JD. Disease of the
Vulva. In Novak’s Gynecologic and Obstetric
Pathology. Eighth edition, W. B. Saunders Company,
Philadelphia-London-Toronto-Tokyo, 1979; pp. 1-58. |
| 7. |
Giaquinto C, Mistro AD, Rossi AD, Bdertorelle
R et al. Vulvar carcinoma in a 12-year-old girl with
vertically acquired Human Immunodeficiency Virus Infection.
Paediatrics 2000; 106: 57-60. |
| |
|
SSRIs AND SUICIDE DRUG COMPANIES’ TRIALS ARE INCONCLUSIVE
Data submitted by drug companies for a safety review by the Medicines and Healthcaer Products Regulatory Agency don’t lead to firm conclusions about a possible association between selective serotonin reuptake inhibitors (SSRIs) and suicide in adults. Gunnell and collagues systematically reviewed 477 randomised controlled trials comparing SSRIs with placebo in over 40,000 participants. They found only weak evidence of an increased risk of self harm among patients taking SSRIs when compared with placebo (odds ratio 1.57, 95% credible interval 0.99 to 2.55).
BMJ, 2005; 330 : 385.
SSRIs AND SUICIDE : RISKS SEEM TO BE SIMILAR TO RISKS WITH TRICYCLICS
The risk of suicide or non-fatal self harm does not seem to differ significantly in patients taking selective serotonin reuptake inhibitors (SSRIs) and those taking tricyclic antidepressants. In a nested case-control study, Martinez and colleagues compared the risks in 146 095 people who were prescribed different antidepressants for the first time. They found some evidence of an association between SSRIs and self harm in people aged 18 or younger (adjusted odds ratio 1.59, 95% confidence interval 1.01 to 2.50), but could not rule out preferential prescribing affecting the results.
The practical implications of these three studies of SSRIs and suicide are discussed in an editorial by Cipriani et al.
BMJ, 2005; 330 : 373, 389. |
|
|
|
*Chief Resident; **Lecturer; ***Professor and Head; Department of Obstetrics and Gynaecology,
Seth GS Medical College, KEM Hospital, Parel, Mumbai – 400 012.
|
|
|